Advance Search
ZHU Yaning. Clinical efficacy and safety of preoperative neoadjuvant chemotherapy combined with parenteral and enteral nutrition support in the treatment of pyloric obstruction of gastric cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 60-63. DOI: 10.7619/jcmp.201913017
Citation: ZHU Yaning. Clinical efficacy and safety of preoperative neoadjuvant chemotherapy combined with parenteral and enteral nutrition support in the treatment of pyloric obstruction of gastric cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 60-63. DOI: 10.7619/jcmp.201913017
shu

Clinical efficacy and safety of preoperative neoadjuvant chemotherapy combined with parenteral and enteral nutrition support in the treatment of pyloric obstruction of gastric cancer

  • Department of Internal Medicine, Binzhou People′s Hospital, Binzhou, Shaanxi, 713500

More Information
  • Received Date: March 28, 2019
  • Accepted Date: May 05, 2019
  • Available Online: February 23, 2021
  • Published Date: July 14, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the clinical effect and safety of preoperative neoadjuvant chemotherapy combined with parenteral and enteral nutrition support in the treatment of pyloric obstruction of gastric cancer.
      Methods  The clinical data of 90 patients with pyloric obstruction of gastric cancer treated in our hospital in recent years were retrospectively analyzed, among whom 45 patients received preoperative neoadjuvant chemotherapy alone were selected as the reference group and 45 patients received preoperative neoadjuvant chemotherapy combined with parenteral as well as enteral nutrition were selected as the observation group. The nutritional status, short-term and long-term prognosis of the two groups were observed.
      Results  Before intervention, there were no significant differences between the two groups in the subjective total nutrition assessment (PG-SGA) score and the quality of life assessment scale (QOL) score (P>0.05). After intervention, the PG-SGA scores of the observation group was significantly lower, and the QOL score was significantly higher than that of the reference group(P < 0.05). The resection rate of tumor and radical resection rate were significantly higher, and the incidence of postoperative complications was significantly lower than that of the reference group (P < 0.05). The recurrence rate, metastasis rate and mortality rate within 3 years after operation of the observation group were significantly lower than those of the reference group (P < 0.05).
      Conclusion  Preoperative neoadjuvant chemotherapy combined with parenteral as well as enteral nutrition support in the treatment of pyloric obstruction of gastric cancer can improve the nutritional status of the body and the quality of life of patients. Meanwhile, it can improve the short-term and long-term effect of surgery, and reduce the risk of complications.
    • FullText(HTML)
    • References (20)
  • [1]
    白亚娜, 曲红梅, 蒲宏全, 等. 金昌队列人群癌症疾病负担分析[J]. 中华流行病学杂志, 2016, 37(3): 306-310. doi: 10.3760/cma.j.issn.0254-6450.2016.03.002
    [2]
    施敏, 张俊, 朱正纲, 等. 从全程管理角度看进展期胃癌围手术期治疗的布局与策略[J]. 中华胃肠外科杂志, 2018, 21(10): 1093-1098. doi: 10.3760/cma.j.issn.1671-0274.2018.10.003
    [3]
    王民开, 夏亚兰, 吴忠亮, 等. 两种新辅助化疗方案联合手术治疗进展期胃癌的疗效比较[J]. 重庆医学, 2018, 47(28): 3708-3709, 3711. doi: 10.3969/j.issn.1671-8348.2018.28.029
    [4]
    饶芸, 骆群, 徐萍, 等. 局部进展期胃癌患者新辅助化疗后围手术期的临床观察[J]. 第三军医大学学报, 2018, 40(22): 2098-2101. https://www.cnki.com.cn/Article/CJFDTOTAL-DSDX201822015.htm
    [5]
    张峻, 王跃, 赵岩, 等. 肠外营养支持对胃癌新辅助化疗病人围术期营养状态和免疫功能的影响[J]. 肠外与肠内营养, 2017, 24(4): 209-212. https://www.cnki.com.cn/Article/CJFDTOTAL-CWCN201704005.htm
    [6]
    李宁. 围术期营养支持治疗的研究进展[J]. 中华消化外科杂志, 2015, 14(5): 355-357. doi: 10.3760/cma.j.issn.1673-9752.2015.05.001
    [7]
    李静, 毛志音, 李怡霖. 患者自评-主观全面评定量表及营养干预在胃肠道肿瘤患者中的应用效果[J]. 中国全科医学, 2017, 20(S2): 144-146. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX2017S2055.htm
    [8]
    徐晓宁. FOLFOX6方案与XELOX辅助化疗方案在胃癌术后的应用及生存差异[J]. 重庆医学, 2017, 46(23): 3272-3274. doi: 10.3969/j.issn.1671-8348.2017.23.033
    [9]
    王永红. 恶液质与肠道细菌移位对局限型进展期胃癌患者临床结局的影响[J]. 实用癌症杂志, 2014, 29(2): 191-193. doi: 10.3969/j.issn.1001-5930.2014.02.025
    [10]
    杨昆, 胡建昆. 合并单个不可根治因素进展期胃癌患者治疗的选择: 基于REGATTA研究的思考[J]. 中华胃肠外科杂志, 2017, 20(3): 347-348. doi: 10.3760/cma.j.issn.1671-0274.2017.03.026
    [11]
    孙娜娜, 刘畅, 冯秋霞, 等. 胃癌腹膜腔转移CT检查的影像学表现[J]. 中华消化外科杂志, 2017, 16(11): 1154-1159. doi: 10.3760/cma.j.issn.1673-9752.2017.11.016
    [12]
    帅晓明, 高金波, 刘兴华, 等. 新辅助化疗联合腹腔镜辅助胃癌根治术治疗进展期胃癌的疗效分析[J]. 中华消化外科杂志, 2016, 15(3): 241-246. doi: 10.3760/cma.j.issn.1673-9752.2016.03.007
    [13]
    王玮, 孙哲, 邓靖宇, 等. 基于多中心大样本数据库的胃癌外科治疗相关数据的整合与分析[J]. 中华胃肠外科杂志, 2016, 19(2): 179-185. doi: 10.3760/cma.j.issn.1671-0274.2016.02.014
    [14]
    崔勇, 张荣香, 王福立, 等. 新辅助化疗联合术后同步放化疗治疗Ⅲ期胃癌的疗效分析[J]. 中国肿瘤临床, 2016, 43(17): 747-752. doi: 10.3969/j.issn.1000-8179.2016.17.389
    [15]
    吴留成, 黄名威, 覃宇周, 等. 进展期胃癌新辅助化疗原发灶病理完全缓解5例报告及文献复习[J]. 中国肿瘤临床, 2016, 43(6): 265-270. doi: 10.3969/j.issn.1000-8179.2016.06.436
    [16]
    杨立平, 李晓峰, 耿兴隆, 等. 进展期胃癌患者腹腔镜微创切除术前应用新辅助化疗的效果分析[J]. 中国药房, 2017, 28(27): 3797-3800. doi: 10.6039/j.issn.1001-0408.2017.27.15
    [17]
    左文述, 郑美珠, 韩超. 新辅助化疗对可手术乳腺癌患者总体治疗策略影响的思考[J]. 中华肿瘤杂志, 2017, 39(12): 952-957. doi: 10.3760/cma.j.issn.0253-3766.2017.12.014
    [18]
    杨成刚, 邵峰, 杨道贵, 等. 氟尿嘧啶、多西他赛和奥沙利铂新辅助化疗联合肠内肠外营养治疗胃癌伴幽门梗阻兔模型的研究[J]. 中华实验外科杂志, 2016, 33(10): 2347-2350. doi: 10.3760/cma.j.issn.1001-9030.2016.10.030
    [19]
    段景琪, 李明阳, 靳英, 等. 胃窦部淋巴瘤致幽门梗阻后空肠营养加静脉营养治疗1例[J]. 中华老年医学杂志, 2017, 36(2): 221-223. doi: 10.3760/cma.j.issn.0254-9026.2017.02.024
    [20]
    翟泽民, 郭剑, 张蓓蕾, 等. 消化道肿瘤患者术前PG-SGA评分与人体成分的相关性研究[J]. 肿瘤代谢与营养电子杂志, 2016, 3(2): 114-117. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLDX201602018.htm
    • Related Articles

  • Related Articles

    [1]DONG Yindi, WU Ge, LI Guanhua. Efficacy and safety analysis of telitacicept in treatment of IgA nephropathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 62-66. DOI: 10.7619/jcmp.20230316
    [2]ZENG Lian. Efficacy and safety of methotrexate intramuscular injection combined with mifepristone oral administration for ectopic pregnancy[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 49-52. DOI: 10.7619/jcmp.201920014
    [3]DONG Xinqiang, LI Peng, MENG Qingze, SUN Wengong. Efficacy and safety of microsurgery for young male patients with varicocele[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 81-83. DOI: 10.7619/jcmp.201910023
    [4]CHEN Shengpeng, JIANG Qiong. Efficacy and safety of progressive dose-adding of alprazolam midazolam in the treatment of chronic tinnitus[J]. Journal of Clinical Medicine in Practice, 2018, (11): 123-125. DOI: 10.7619/jcmp.201811036
    [5]LIU Zhigang, GONG Haitao. Clinical efficiency and safety of painless gastroscopy[J]. Journal of Clinical Medicine in Practice, 2018, (9): 101-103. DOI: 10.7619/jcmp.201809028
    [6]JIANG Yanli, WANG Xiujun, GAN Xiaoli. Effect of predictive nursing combined with enteral nutrition support on gastrointestinal function and quality of life in patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2016, (10): 51-54. DOI: 10.7619/jcmp.201610017
    [7]DENG Xiaolong, JI Wangqi. Efficacy and safety of hepatic arterial chemoembolization combined with radiofrequency ablation in treatment of patients with liver cancer[J]. Journal of Clinical Medicine in Practice, 2016, (3): 46-48,55. DOI: 10.7619/jcmp.201603014
    [8]FANG Chongwen. Efficacy and safety of endoscopic submucosal dissectionin the treatment of patients with digestive tract tumor[J]. Journal of Clinical Medicine in Practice, 2015, (21): 34-37. DOI: 10.7619/jcmp.201521009
    [9]WANG Jinwan, CAO Huqiang. Clinical efficacy and safety of 3-dimensional conformal radiotherapy combined with GT chemotherapy in the treatment of malignant bladder tumor[J]. Journal of Clinical Medicine in Practice, 2015, (19): 44-47. DOI: 10.7619/jcmp.201519013
    [10]ZHANG Ying. Efficacy and safety of montelukast in the treatment of cough variant asthma in infants[J]. Journal of Clinical Medicine in Practice, 2015, (11): 145-146. DOI: 10.7619/jcmp.201511051

  • Cited by

    Periodical cited type(5)

    1. 万建平，周强. 经直肠超声造影检查联合血清前列腺特异性抗原检测对前列腺癌的诊断及预后预测价值. 癌症进展. 2025(02): 236-239 .
    2. 李正平，李永芬，王生鹏. 前列腺尿道悬吊术对小体积良性前列腺增生患者下尿路功能、血清炎症-应激因子、并发症的影响. 微创泌尿外科杂志. 2025(01): 31-37 .
    3. 王安勇，高余杰，黄学东，张衡，朱杰. 尿道前列腺切除术联合经尿道膀胱取石治疗老年前列腺增生伴膀胱结石的疗效及预后. 中国临床医生杂志. 2024(03): 290-294 .
    4. 潘宗森，王慧. 经尿道前列腺钬激光剜除术在大体积良性前列腺增生中的应用效果. 浙江创伤外科. 2024(03): 538-541 .
    5. 黄登辉，周广臣. 前列腺特异性抗原灰区患者前列腺穿刺活检结果的相关影响因素分析. 实用临床医药杂志. 2023(15): 77-81 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (306) PDF downloads (3) Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return